The plausibility of a role for mercury in the etiology of autism: a cellular perspective by Garrecht, Matthew & Austin, David W.
Toxicological & Environmental Chemistry
Vol. 93, Nos. 5–6, May–July 2011, 1251–1273
The plausibility of a role for mercury in the etiology of autism:
a cellular perspective
Matthew Garrecht and David W. Austin*
Swinburne Autism Bio-Research Initiative, Faculty of Life and Social Sciences,
Swinburne University of Technology, Hawthorn, Victoria 3122, Australia
(Received 8 December 2010; final version received 10 April 2011)
Autism is defined by a behavioral set of stereotypic and repetitious behavioral
patterns in combination with social and communication deficits. There is
emerging evidence supporting the hypothesis that autism may result from a
combination of genetic susceptibility and exposure to environmental toxins at
critical moments in development. Mercury (Hg) is recognized as a ubiquitous
environmental neurotoxin and there is mounting evidence linking it to
neurodevelopmental disorders, including autism. Of course, the evidence is not
derived from experimental trials with humans but rather from methods focusing
on biomarkers of Hg damage, measurements of Hg exposure, epidemiological
data, and animal studies. For ethical reasons, controlled Hg exposure in humans
will never be conducted. Therefore, to properly evaluate the Hg-autism etiological
hypothesis, it is essential to first establish the biological plausibility of the
hypothesis. This review examines the plausibility of Hg as the primary etiological
agent driving the cellular mechanisms by which Hg-induced neurotoxicity may
result in the physiological attributes of autism. Key areas of focus include:
(1) route and cellular mechanisms of Hg exposure in autism; (2) current research
and examples of possible genetic variables that are linked to both Hg sensitivity
and autism; (3) the role Hg may play as an environmental toxin fueling the
oxidative stress found in autism; (4) role of mitochondrial dysfunction; and
(5) possible role of Hg in abnormal neuroexcitory and excitotoxity that may play
a role in the immune dysregulation found in autism. Future research directions
that would assist in addressing the gaps in our knowledge are proposed.
Keywords: autism; mercury; cellular; oxidative stress; mitochondrial; immune
dysfunction
Introduction
Rather than critically examining the extensive literature relating to the possible role of Hg
in the etiology of autism, this review focused specifically on the biological plausibility of
the hypothesis from a cellular perspective. This is an essential prerequisite for furthering
our understanding of Hg’s possible role in autism because, for ethical reasons, one cannot
conduct experimental Hg trials on humans. Instead, one needs to rely on the broad
discipline of epidemiology to bring together disparate lines of inquiry and methodologies
that inform the area. Independent and a priori of this, it is of fundamental importance to
evaluate the biological plausibility of the hypothesis. A body of epidemiological evidence
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Autism is a behaviorally defined neurodevelopmental disorder first characterized in the
early 1940s by psychiatrist Kanner (1943). Autism is defined by a set of key features that
include social interaction and communication impairments plus the presence of repetitive
and stereotypic patterns of behavior (American Psychiatric Association [APA] 1994).
In addition, autism is associated with symptoms such as mental retardation, seizures,
gastrointestinal problems, and autoimmune dysfunctions (Rao et al. 2009).
For the first few decades following the seminal paper by Kanner (1943), autism
appeared to be a rare mental disorder. However, epidemiological data gathered over the
past couple of decades indicate that the prevalence of autism is on the rise (Newschaffer
et al. 2007). Current estimates of autism prevalence range from 1 in 150 to 1 in 91 children
in the USA (Kogan et al. 2009; Rice 2009). Although the cause of this change in prevalence
is somewhat unclear, it is reasonable to assume that it is to some degree due to a
broadening in diagnostic criteria and increased public awareness. Nevertheless, several
studies have not been able to fully explain the rise in prevalence by these factors alone,
which suggests the possible involvement of environmental factors (Grether et al. 2009;
Hertz-Picciotto and Delwiche 2009; King and Bearman 2009). The progression of autism
from a rare condition to a widespread public health concern has led to an increase in
scientific research focused on biological and etiological theories of the condition. Although
the etiology of autism remains uncertain, there is emerging evidence that exposure to
environmental toxins at critical moments in prenatal and postnatal periods plays an
important role in the development of autism (Austin 2008; Deth et al. 2008; Herbert 2010).
Mercury has been known for its potent neurotoxicity for centuries, yet is often used in
a variety of medicinal, commercial, and industrial practices (Clarkson 2002). Mercury is
classified by three specific species: elemental (Hg
0), inorganic salts (e.g., HgCl2), and
organic (methyl and ethyl mercury). As a ubiquitous natural element, Hg cycles from the
air as vapor to the water or soil, where upon it is either vaporized or converted to an
organic form. Hg vapor disseminates into the air from various sources both natural and
industrial, such as in volcanic eruptions, gold refining processes, and coal burning.
Environmental Hg spreads far from the original source and eventually enters the biosphere
(Agency for Toxic Substances and Disease Registry 1999; Clarkson 2002). Apart from
environmental Hg, additional sources of exposure in humans include the vaccine
preservative thimerosal (or thiomersal), lab accidents, and other accidental exposures
such as those of old thermometer breakages (Zahir et al. 2005). Dental amalgams may be a
significant source of inorganic Hg entering the blood stream via inhalation of Hg vapor
produced from actions such as chewing. Amalgams are of concern as they contribute to
the Hg burden of adults as well as the embryo and fetus in the presence of maternal
amalgam fillings (Mutter 2007).
Several recent studies profiled the prevalence of autism and its relation to environ-
mental factors such as proximity to coal-burning power plants, atmospheric pollution
(Windham et al. 2006; DeSoto 2009), as well as more specifically to Hg (Austin 2008; Rose
et al. 2008; Palmer et al. 2009; Schweikert et al. 2009). However, while these studies do not
support causation, they do support a plausibility argument that Hg may be involved and
warrants further investigation.
The topic of much heated debate in the broader autism area has been vaccinations;
more specifically, the inclusion of thimerosal as a preservative in vaccines given to children
and pregnant women (Blaxill et al. 2004; DeSoto and Hitlan 2010; Schultz 2010).
Thimerosal is a long-chain alkyl Hg compound which is approximately 50% Hg by weight.
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the blood–brain barrier, after which it is broken down into inorganic Hg (Hoffman et al.
2007). It seems logical to make the assumption that vaccination is a cause of autism due to
the simular temporal period in which the first signs of autism occur and modern
vaccination schedules are administered. However, numerous epidemiological studies
reviewed by Schultz (2010) are not able to support such an association and those that
do have some severe limitations. Another more recent study was not able to support a
clear association between increased risk of autism and Hg-containing vaccinations
(Price et al. 2010).
Despite the lack of a clear association based on epidemiological studies, a recent pilot
study examining Hg-containing vaccines in infant Rhesus monkeys found effects on parts
ofthebrainthatarelinkedtoautism(Hewitson,Lopresti, etal.2010).Anotherrecentstudy
by Hewitson, Houser, et al. (2010) examined the effect of thimerosal-containing Hepatitis-B
vaccines in infant Rhesus macaques who received the vaccination within 24h of birth. The
study found that infants who received the Hg-containing vaccine suffered neurodevelop-
mental delays with gestational age and birthweight being contributing factors. This is
interesting, especially in light of another recent study in which an increased risk of autism
was associated with boys who had received the Hepatitis-B vaccine in the first month of life
(Gallagher and Goodman 2010). Vaccinations are not the only source of Hg exposure in
children (Counter et al. 2002; Counter and Buchanan 2004) and, indeed, the pathophys-
iology of Hg-inducedtoxicity isstill not understood enough,especially in developing fetuses
and newborns, to dismiss the hypothesis on the basis of vaccine studies.
Mercury: evident exposure in children
Mercury is toxic mainly due to its high affinity for sulfur groups present in numerous
cellular proteins, which remains true for all species of Hg (Clarkson 2002). Differences in
symptoms from intoxication of the various Hg species are postulated to be due to
differences in metabolism and transportation to the target tissues (Castoldi et al. 2001).
The central nervous system (CNS) is one of the major targets of Hg and both high- and
low-dose exposures often produce significant and long-term neurological damage (Zahir
et al. 2005; Johansson et al. 2007).
The clinical symptoms of the various species of Hg depend greatly on the dose, pattern,
timing and route of exposure, individual excretion rates, and idiosyncratic sensitivity to
Hg (Clarkson 1997; Blaxill et al. 2004). The neurological symptoms attributed to Hg
intoxication are usually most evident and include ataxia, deafness, psychosis, loss of
speech, erethism, and constriction of the visual field (Ceccatelli et al. 2010). There have
been several studies examining the effects of Hg on children (Counter et al. 2002; Counter
and Buchanan 2004). Studies consist mainly of the large exposures to methyl-mercury
(MeHg) in Japan and Iraq (Matsumoto et al. 1965; Bakir et al. 1973; Amin-Zaki et al.,
1974; Harada 1978; Harada et al. 1999), smaller but widespread exposures to inorganic Hg
which produced pink disease or acrodynia (Dally 1997) and coastal communities which
consume high amounts of seafood which contain MeHg (Kjellstrom et al. 1986, 1989;
Myers, Davidson, et al. 1995; Myers, Marsh, et al. 1995; Grandjean et al. 1997, 1998).
One of the major factors contributing to MeHg toxicity is its ability to accumulate in
biological organisms. This bioaccumulation occurs when Hg from environmental sources
is methylated by microbes and then consumed or absorbed by both plants and animals,
especially aquatic animals such as fish and crustaceans (Morel et al. 1998). The presence of
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animals such as birds and mammals with a diet high in seafood through a process termed
biomagnification.
Even in communities where fish consumption is not high, the level of organic Hg was
shown to be higher in pregnant women with a diet of local or commercially bought fish
than in pregnant women who had not consumed any fish during pregnancy (Morrissette
et al. 2004). In a recent study, the levels of Hg decreased over the course of the pregnancy
in both mothers who had consumed fish and those that had not. However, despite this fall
in the mother, the levels of Hg in the umbilical cord blood at birth was double than that in
the mother (Morrissette et al. 2004; Schoeman et al. 2010). This phenomenon whereby the
placenta not only fails to protect the fetus from Hg exposure but, rather, facilitates
preferential movement of Hg to the fetus, was also a noted feature of the Minamata
disease outbreak in Japan (Sakamoto et al. 2010). As a well-founded cautionary measure,
it has been recommended that, during pregnancy, the consumption of fish be restricted to
two meals per week of low Hg-containing fish and the strict avoidance of high Hg-
containing fish such as Shark, Swordfish, and King Mackerel (U.S. Food and Drug
Administration 2004; Koren and Bend 2010).
While most studies looked at the effects of high dosage, acute toxicity, comparatively
few have examined low-dose chronic Hg toxicity. This inequity is especially egregious
considering that this latter exposure pattern is the pattern that the vast majority is exposed
to (Zahir et al. 2005). Furthermore, this issue is particularly important to children at both
prenatal and postnatal stages of development as they are particularly vulnerable to Hg
(Counter and Buchanan 2004). There have been several major studies which have
examined the neurological outcomes of children in coastal communities in which high-
seafood diets may have led to a higher then average prenatal and postnatal
MeHg exposures (Kjellstrom et al. 1986, 1989; Myers, Davidson, et al. 1995; Myers,
Marsh, et al. 1995; Grandjean et al. 1997, 1998; Oken et al. 2008). Overall, the conclusions
from these studies on the effect of this low-level MeHg exposure on the neurological
outcomes of the children have been mixed. It is most likely that the data from these studies
are confounded by the dietary benefits of seafood consumption. Confounding factors
beneficial to neurodevelopment, such as long-chain polyunsaturated fatty acids and
selenium, are found in fish and are likely to cause an underestimation of MeHg-induced
toxicity (Choi, Cordier, et al. 2008).
The pink disease outbreak of the twentieth century highlights the potential severity of
the reaction (including death) that some children may have to a low level of Hg exposure
(Black 1999), and it is this variable, idiosyncratic, and unpredictable individual suscepti-
bility to Hgthatdeterminesthe reaction. Inthe early1900s, theincreased availabilityof new
pharmaceuticalsledtotheexposureofinfantstoinorganicHgpresentascalomelinteething
powder (Black 1999). Calomel contained Hg levels low enough to not be poisonous to the
average infant. However, for a small subset of the population highly susceptible to Hg, the
levels were sufficient to be detrimental and produce symptoms which would eventually be
classified as a disease entity: pink disease or acrodynia (Dally 1997). This disease highlights
the importance of understanding the pathophysiology of Hg in children, which would
enable identification of those most at risk to environmental Hg. Indeed, in a recent study
examining the prevalence of developmental disorders amongst grand-children of survivors
of pink disease, a 7-fold higher rate of autism was found compared to the general
population,suggestingagenetic(oratleasthereditary)basisforthepossibleroleofmercury
in the etiology of autism (Shandley and Austin in press).
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Bernard et al. (2001) published an article reviewing the similarities between the symptoms
of Hg intoxication and the symptoms of autism. The claimed neurological similarity
between autism and Hg poisoning was debated by Nelson and Bauman (2003), a paper
which in turn was disputed by Blaxill et al. (2004). A short section in the Nelson and
Bauman’s (2003) article contends that the lack of any scientific papers describing the
presence of abnormal Hg body burdens within autistic children does not lend support to
a Hg–autism association. However, this is not exactly the case. Outlined in the recent
reviews by Schultz (2010) and Geier et al. (2008), there have been several studies examining
potential Hg exposure and Hg body burdens in autistic children (Bradstreet et al. 2003;
Holmes et al. 2003; Fido and Al-Saad 2005; Adams, Romdalvik, et al. 2007; Adams et al.
2008; DeSoto and Hitlan 2007; Kern et al. 2007; Williams et al. 2008; Geier et al. 2009c;
Hertz-Picciotto et al. 2010). These studies employed various methods and looked at a
range of Hg sources (e.g., fish consumption, dental amalgams, and vaccinations) in a range
of children within the autism spectrum. Some studies (Adams et al. 2006; Kern et al. 2007)
examined a wide array of toxic heavy metals from hair samples obtained from children
diagnosed with autism and neurotypical children but found no significant difference in the
Hg concentrations between them. However, studies do describe a somewhat impaired
ability to excrete heavy metals in general.
Numerous studies (Holmes et al. 2003; Fido and Al-Saad 2005; Adams, Romdalvik,
et al. 2007; Adams et al. 2008; Kern et al. 2007) analyzed the Hg concentrations within
hair and teeth samples from autistic children and then matched them against neurotypical
controls. The studies which examined samples from older autistic children (44 years old)
found a higher concentration of Hg in autistic children when compared to the neurotypical
children. However, the studies which analyzed samples taken at the time of the baby’s first
haircut or teeth taken from autistic children aged 12–24 months found that Hg
concentrations were lower than neurotypical children. This relationship between age
and Hg levels is also a major finding in a recent study (Majewska et al. 2010) in which the
levels of hair Hg between two age groups (group 1 aged 3–4 and group 2 aged 7–9) of
autistic children were compared. The results indicated that compared to the control
children, the younger autistic group had significantly lower hair Hg concentrations while
the older autistic group had significantly higher hair Hg concentrations. It was suggested
that this discrepancy in Hg body burdens was due to an impaired ability to excrete Hg in
younger autistic children.
In further support of an abnormal Hg body burden in autistic children, Holmes et al.
(2003) found that an increase in autism severity correlated to a lower concentration of
Hg in the hair samples taken at the time of their first haircut (around 11–24 months).
This was despite an estimated increase in Hg exposure in autistic children than in
neurotypical children. A similar conclusion was reached by Geier et al. (2009c), who
found that a rise in autism severity correlated with an elevation in the number of dental
amalgams in the mother during pregnancy, and thus an increased risk of fetal Hg
exposure. In a study by Bradstreet et al. (2003), looking at 221 autistic children aged
between 3 and 15 years of age, a rise in urine Hg concentrations was found after 3 days
of heavy metal chelation therapy, again supporting the hypothesis that autistic children
do not eliminate Hg efficiently as normal children. The data from these studies support
the plausibility that autistic children have an elevated risk of sustaining damage from an
exposure to Hg due to this reduced capacity to effectively excrete Hg compared to non-
autistic children.
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of accuracy in determining the dose of Hg exposure in autistic and normal controls. In
addition, there are also studies which do not support the hypothesis. Williams et al.
(2008) released a study comparing 15 autistic children of age 2–6 years and their gender-
and age-matched neurotypical sibling controls. Williams et al. (2008) found no
significant difference between the Hg concentrations in the hair samples obtained
from these two groups. In a recent study (Hertz-Picciotto et al. 2010), no significant
difference was noted in a comparison between blood Hg concentrations of 249 autistic
children (around 2–5 years of age) and 143 neurotypical children. However, this study
recognized that because the half-life of inorganic Hg and MeHg is around 60–90 days
(Clarkson 1997) and this was a measurement of a single-time event, it could not
evaluate any possible differences in Hg excretion rates between autistic and neurotypical
groups. While it is clear that more research is needed to bring more clarity to the
hypothesis that an abnormal Hg body burden exists within autistic children, the above
studies do imply that autistic children may be more susceptible to Hg damage than non-
autistic children.
Recently, biomarkers of Hg damage have been explored by looking at urinary
porphyrins (Nataf et al. 2006; Austin and Shandley 2008). Porphyrins are a necessary
intermediate in heme production and have a well-established metabolism and excretion
pathway. This pathway is affected by exposure to specific heavy metals interfering with
the enzymes uroporphyrin decarboxylase and coproporphyrinogen oxidase. Mercury
exposure was shown to elevate levels of pentacarboxyl (5Cxp), precoproporphyrin
(PrCp), and coproporphyrin detectable in urine (Woods et al. 1991). There are an
increasing number of studies finding an elevation in these porphyrins in autistic children
(Geier and Geier 2006b; Nataf et al. 2006; Austin and Shandley 2008). Recently, in a
group of 65 autistic children, Youn et al. (2010) found elevated levels of both 5Cxp and
PrCp, which were in concordance with previous studies. These findings are further
supported in a recent study by Woods et al. (2010), in which samples from 218 children
aged 2–12 were examined.
This latter study is interesting because, first, it shows increased levels of PrCp in
normal children, which suggests a degree of elevation of this porphyrin is a natural
occurrence in young children. However, the levels of PrCp and 5Cxp were still
significantly higher in children with autism compared to age-matched controls which
is concordant with the aforementioned studies. Woods et al. (2010) attempted to
measure the background Hg exposure levels of these children by surveying potential
Hg risk factors the child and mother may have been exposed to. The resulting
survey data revealed no significantly different level of Hg exposure occurred between
the two groups. This seems to be consistent with a genetically mediated pathogenesis
of autism whereby, given equal Hg exposure, only a small minority of particularly
Hg-sensitive individuals will manifest autism. Woods et al. (2010) concluded that
porphyrin disruption may be an important characteristic in autism, suggesting that
genetic polymorphisms in the enzyme coproporphyrinogen oxidase (CPOX4) could
be associated with increased autism risk. Interestingly, polymorphisms in CPOX4
have also been associated with an increase in sensitively to Hg neurotoxicity
(Echeverria et al. 2006). If this is the case, it will be important to monitor the levels
of exposure, identify susceptible persons in the population, and to understand
the actual mechanisms that may link the neurotoxicity of Hg and the etiology of
autism.
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Electrons that ‘‘leak’’ from the electron transport chain within the mitochondria are
accepted by O2 and create a whole range of reactive oxygen species (ROS; Halliwell 1992).
The build-up of ROS leads to a state of oxidative stress resulting in: (1) oxidation of lipid
membranes, (2) the deleterious alteration of proteins, and (3) activation of apoptotic
mechanisms (Valko et al. 2007). The potentially damaging oxidative environment is
controlled by a collection of reducing elements such as superoxidase dismutase,
glutathione peroxidase (GPx), and catalase, as well as small molecules such as glutathione
(GSH) and vitamin E (Schulz et al. 2000; Oktyabrsky and Smirnova 2007). Glutathione
is a tripeptide (-glutamyl-cysteinylglycine) consisting of a glutamate and disulfide that
allows it to bind to free radicals and donate an electron. It is considered to be the major
antioxidant molecule in the body due to the numerous roles it plays in maintaining a redox
balance, high abundance, and endogenous production (Townsend et al. 2003).
The antioxidant mechanisms of GSH involve the action of two enzymes: GPx and
glutathione reductase (GR). GPx is the enzyme responsible for the reduction of peroxide
and other oxidized lipid molecules. The reduction of these toxic molecules requires GPx
to oxidize GSH, which in turn results in the production of oxidized GSH (GSSG;
glutathione disulfide; Dringen 2000; Franco et al. 2009). The fate of GSSG is either to be
removed from the cell or to be reverted back to GSH by the enzymatic action of GR with
the addition of NADPH. Thus, maintenance of the necessary levels of GSH is both
dependent on de novo synthesis and the levels of GR (Dringen et al. 2000). The ratio of
GSH/GSSG has been shown to be important in the activation of enzymes in catabolic and
metabolic pathways (Fratelli et al. 2002). In the mitochondria, however, the levels of GSH
are dependent on the functional levels of GR and NADPH in order to reduce GSSG and
maintain the GSH:GSSG ratio (Lash 2006; Hu et al. 2008). The reduction of GSSG to
GSH inside the mitochondria is important for two reasons: (1) the production of ROS as
stated above and (2) GSSG can form disulfide bonds with complex I of the electron
transport chain in the mitochondria resulting in the increased production of superoxides,
which can lead to mitochondrial dysfunction (Taylor 2003).
The brain is more susceptible to oxidative stress than other tissues in the body due to its
high oxygen demands as well as containing a high degree of polyunsaturated fats, which
are sensitive to ROS attacks. The brain also has limited protective mechanisms against
ROS build-up, as well as higher % mitochondria due to brain energy requirements
(Halliwell 1992; Singh et al. 2004). The presence of high oxidative stress is a characteristic
of autism (James et al. 2004; Kern and Jones 2006; Deth et al. 2008) as well as
neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases (Kidd 2005).
Mercury readily crosses the blood brain and placental barriers, where upon it enters the
cell and binds to its numerous targeted thiol groups (Taber and Hurley 2008; Ceccatelli
et al. 2010). In vitro, Hg has the ability to damage cell membranes and deoxyribonucleic
acid (DNA) at micromolar concentrations particularly in neuronal cells, which were
shown to be more sensitive than other cell types (Baskin et al. 2003). Methyl-mercury is
considered to be highly neurotoxic as it has been shown to enter the brain more effectively
than other organic Hg compounds (Magos 2003; Harry et al. 2004). The reason for this is
due to the sterospecific transport of cysteine–MeHg compounds into astrocytes via neutral
amino acid transport systems. While this ubiquitous amino acid transport system has been
identified as one of the transport mechanisms in the brain, the particular mechanisms by
which MeHg actively enters the cell is still unclear (Heggland et al. 2009). At present,
a complete understanding of the mechanisms underlying Hg neurotoxicity remains
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(Sarafian et al. 1994; Shenker et al. 2002) while also decreasing the levels of GSH which is
an important factor in protecting against the cytotoxicity of Hg (Woods and Ellis 1995;
Olivieri et al. 2000; James et al. 2005).
The essential nutrient selenium has also been identified as important in redox
mechanisms (in the form of GPx and selenoproteins) as well as being potentially protective
against the neurotoxicity of Hg (Whanger 2001). The protective mechanisms of
selenoproteins are thought to be due to both their high affinity for binding Hg and
their role in counteracting Hg-induced ROS damage (Chen et al. 2006). However, the
relationship between selenoproteins and Hg in terms of neurological and neurodevelop-
ment disease is not clear and requires further research (Choi, Budtz-Jørgensen, et al. 2008;
Battin and Brumaghim 2009).
There have been numerous studies that examined oxidative stress in autism by
measuring biomarkers indicative of oxidative stress. Although it seems clear that at least
a subset of autistic children suffer from elevated oxidative stress, it is not clear what the
cause of this redox imbalance is. Several studies examined autism as a metabolic disease
(Sogut et al. 2003; James et al. 2004, 2008, 2009, 2010; Geier and Geier 2006a; Kern and
Jones 2006; Suh et al. 2008; Adams et al. 2009; Al-Gadani et al. 2009; Geier et al. 2009a,
2009b). Among these studies, an examination of trans-sulfuration pathways is common.
This typically involves measurement of various metabolites from venous blood which
include cysteine, cystine, GSH, and GSSG as well as components of the methionine
pathway (methionine, S-adenosylmethionine, and S-adenosylhomocysteine).
At present, most studies examining metabolic factors in children with autism have used
blood plasma to test for biomarkers such as levels of carnitine, the S-adenosylmethionine/
S-adenosylhomocysteine ratio or the GSH:GSSG ratio. However, a recent study by James
et al. (2009) used autistic cell lines to examine the cell ability to maintain a redox balance
under stress conditions. The study examined both the cytosolic and mitochondrial
GSH:GSSG ratios as a measurement of the redox potential. James et al. (2009) found that
both mitochondrial and cytosolic redox states were imbalanced containing higher levels of
GSSG then normal. However, interestingly the mitochondria had a significantly lower
GSH:GSSG ratio compared to that in the cytosol, suggesting that mitochondrial function
may be particularly impaired in autism.
In the same study, the Hg-based vaccine preservative thimerosal did not appear to
significantly decrease the amount of GSH in autism cell lines over the control cells.
However, it was suggested that as autism cells already have a compromised redox
imbalance, any further reduction by external factors, such as environmental insults from
Hg, will be less obvious. This also concurs with the evidence that Hg diminishes
antioxidant protection and increases ROS production (Sarafian and Verity 1991; Ou et al.
1999; Allen et al. 2001). MeHg was shown to impair GPx activity in rats (Dringen et al.
2000), decrease glutamine uptake, and increase mitochondrial membrane permeability
(Yin et al. 2007).
Autism has been reported to affect more males than females in a ratio of 4:1 (Yeargin-
Allsopp et al. 2003). This is an interesting phenomenon in relation to the toxicology of Hg.
Studies in rats showed male rats to be significantly more susceptible to the adverse effects
of inorganic Hg (Ekstrand et al. 2010) and also, more recently, to thimerosal (Branch
2009). The mechanisms underlying this gender disparity seem to be linked to differences in
testosterone and estrogen levels, as testosterone was found to increase the toxicity of Hg,
while estrogen was reported to be protective against Hg damage (Muraoka and Itoh 1980).
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neurons (Olivieri et al. 2002; Nilsen 2008).
The consistent finding in autistic children is the decrease in cystine, cysteine, GSH, as
well as an elevation in oxidized GSSG, all of which are indicative of oxidative stress. There
are also reports indicating an abnormal decrease in S-adenosylmethionine/S-adenosylho-
mocysteine ratio (James et al. 2004). This is important in the methylation of protein and
DNA, in which a fall is likely to also reduce protein synthesis as well as affect levels of
GSH and cysteine. There is concordance among the research that although the underlying
mechanisms of oxidative stress in autism are not definitively confirmed, the possibility that
environmental toxins (especially Hg) fuel oxidative stress is plausible.
Mercury and mitochondrial dysfunction
As mitochondria is the cellular powerhouse and also one of the major targets of oxidative
stress, having a compromised redox balance is more likely to be detrimental to
mitochondria. This is because in mitochondria, GSSG is not transported rapidly across
mitochondrial membranes under conditions of oxidative stress like in the cytosol but is
dependent on NADPH and GR reducing it to GSH (Olafsdottir and Reed 1988; Garcia
et al. 2010). Mitochondrial dysfunction was shown to play a role in producing oxidative
stress within a cell. Mitochondrial dysfunction is also suspected to play a role in autism as
studies identify reduced activity of electron transport chain enzymes (especially ETC
complexes 1, 3, and 4) and other biomarkers of mitochondrial dysfunction in autistic
children (Oliveira et al. 2005; Weissman et al. 2008; Ezugha et al. 2010). In a recent review
(Gargus and Imtiaz 2008), the mechanisms and mitochondrial mutations that might be
involved in autism are discussed in detail.
In a recent study by Monroe and Halvorsen (2009), environmental toxins (Hg,
cadmium, and the pesticide rotenone) were used to examine the mechanisms by which
oxidative stress produces damage in neuronal cells compared to non-neuronal cells. It was
found that the generation of ROS and the dysfunction of the mitochondria resulted in the
inhibition of the Janus kinase (JaK) and signal transducer and activator of transcription
(STAT) pathways. However, this only occurred in the neuronal cells despite comparable
levels of oxidative stress, toxins, and equal mitochondrial sensitivity to the loss of
membrane potential. It was suggested that there exist differing mechanisms of dealing with
ROS build-up and oxidative stress between neuronal cells and non-neuronal cells. JaK and
STAT are involved in a wide range of cytokine signaling processes as well as in playing an
important role in glial cells (gliogenesis) (Rodig et al. 1998; Aringer et al. 1999; Zhao et al.
2007). The inhibition of neurotropic factors just as JaK–STAT by Hg is thought to be one
of the ways Hg induces neurological damage (Monroe and Halvorsen 2006).
In a study by Nishimura (2007) using lymphoblastoid cell lines derived from autistic
patients, it was shown that an important protein in the JaK pathway (JaK and
microtubule-interacting protein 1) was dysregulated (Steindler et al. 2004; Bill and
Geschwind 2009). It was suggested that this might be involved in the disruption of
glutamate signaling in neurons as well as serve as a possible biomarker for autism,
although the mechanisms for its irregular expression were not clear. This finding combined
with the known effects of Hg-impairing microtubule action (Crespo-Lopez et al. 2009) and
the JaK pathway mentioned above provides compelling evidence that the combination of
Hg exposure during critical periods of brain development and underlying vulnerability
may play a role in autism. However, it is also clear that more research is needed to further
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to support a Hg-autism etiology alone.
Underlying genetic susceptibility to environmental toxins
It is likely that there are genetic predispositions to autism, given the high concordance
between monozygotic twins (Ritvo et al. 1985) and a greater chance of autism recurring
within affected families (Bailey et al. 1995). Thus, there has been extensive research into
the identification of autism-associated or autism-susceptibility genes (Cook 1998; Muhle
et al. 2004; Freitag et al. 2010). While the concordance among twins studies is high, it is
not 100%, which strongly suggests other factors playing a role, such as environmental
factors (Deth et al. 2008) and differences in gene expression as a result of epigenetic factors
(Hu et al. 2006). This has led to research targeting genes associated with environmental
sensitivity and metabolism that might also be involved in autism.
The family of enzymes known as glutathione-S-transferase (GST) play an important
role in the detoxification of the products of oxidative stress and mercury damage such as
hydrogen peroxide (Hayes et al. 2005). Polymorphisms in GST genes have been linked to
an increased sensitivity to thimerosal and are also associated with autism to varying
degrees (Buyske et al. 2006; James et al. 2006). The deletion of GSTM1 was also shown
to affect the neuronal growth of the hippocampus and cerebellum in mice after oxidative
stress was induced (Yochum et al. 2010). Polymorphisms associated with reduced GST
function have also been associated with Hg susceptibility in a number of studies (Westphal
et al. 2000; Gundacker et al. 2007; Lee et al. 2010). In a recent study by Willams et al.
(2007), functional polymorphisms in the GST-P1 genotype was examined among 49
families containing at least one child diagnosed with autism. It was found that a specific
haplotype (313A, 313C) was more frequently transmitted above any others in the study.
While the role this had was not made clear, it was suggested to have a possible teratogenic
effect (Williams et al. 2007).
The abnormal metabolism present in autism suggests the involvement of genes related
to the maintenance and functioning of the methylation and trans-sulfuration pathways
(James et al. 2006). The methionine transmethylation pathway is important in maintaining
the correct functioning of cellular processes via the methylation of DNA, proteins, and
phospholipids (Mato et al. 2002). In this pathway, homocysteine is converted to
methionine via methylation by methionine synthase in a B12-dependent reaction with
5-methyltetrahydrofolate (5-MTHF) acting as the methyl donor. Maintaining the
availability of methionine is essential and there have been several studies looking at the
polymorphisms which may affect this process in autism (James et al. 2004; Mohammad
et al. 2009). The polymorphisms of most concern have been in the MTHF reductase gene,
which reduces 5, 10-methylene-THF to 5-MTHF. However, there are conflicting results
with some studies finding significant associations (Boris et al. 2004; Mohammad et al.
2009; Pasca et al. 2009) and others finding no association with autism (James et al. 2004;
Adams, Lucock, et al. 2007a).
It is likely that these discrepancies are due to the heterogeneous nature of autism and/
or the sample sizes used in the study (Main et al. 2010). However, there are numerous
other genes related to the methionine transmethylation pathway that have been associated
with autism such as reduced folate carrier (James et al. 2010), Transcobalamin II (James
et al. 2006), and dihydrofolate reductase (Adams, Lucock, et al. 2007). This pathway is
also interconnected with the trans-sulfuration pathway, which competes for the
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Therefore, as this process was shown to be important in maintaining both proper
methylation and providing protection against oxidative stress, any dysfunctions due to
underlying genetic traits would make these children susceptible to environmental toxic
insults such as that from Hg (Deth et al. 2008).
A recent review by Gundacker et al. (2010), details what is currently known about
important genetic factors involved in Hg susceptibility, and it also highlights how an
individual genetic background reflects their ability to metabolize Hg. The uptake of Hg by
the amino acid transporter LAT1, encoded by the gene SLC7A5, was shown to affect the
uptake of MeHg in mice, increasing uptake when over-expressed and decreasing when
knocked down (Yin et al. 2008; Nicklin et al. 2009). This gene has also been linked to
autism (Anderson et al. 2009).
Genetic research into autism, while not providing the ultimate break-through that was
hoped for, has at least provided some clues as to the etiology of this complex disorder.
Numerous genes that are important in the metabolism of environmental toxins (but not
limited to Hg) such as a polymorphisms of glutathione peroxidase (GPX1), paraoxonase 1,
and a delta-aminolevulinate dehydratase variant (ALAD2) have also been linked to autism
(Herbert 2010). There is a broad concordance across the disparate lines of inquiry,
suggesting that an individual’s genetic background may influence susceptibility to
environmental insult. The heterogeneity of autism most likely reflects a broad spectrum
of susceptibility, in which specific genotypes may differ between individuals. This has
made establishing the specific autism susceptibility genes so difficult to identify. In
addition, the genetic components which convey sensitivity are still not well established
(Gundacker et al. 2010). This makes establishing strong links with autism difficult and is
an area of much needed research. The apparent overlap between the gene pathways known
to influence Hg defense and their presence in autistic populations supports the plausibility
of the Hg-autism hypothesis.
Glial cells: the central component of excitotoxicity and immunotoxicity
Glial cells are non-neuronal cells that, until recently, were thought only to be involved in
neuronal health and maintenance. However, new insights revealed glial cells to play a
much larger role in information processing and early neurodevelopment (Fields and
Stevens-Graham 2002). There is an indication that the complex mechanisms and
interactions of these non-neuronal cells are important in brain function; however, they
are still not completely understood (Fields 2008). Glial cells do, however, play important
roles in excitotoxicity and immunotoxicity, which are two key aspects involved in the
developmental neurotoxicity of autism.
Astrocytes have been established to be integral to the health and function of neurons
(Fallon 1985). Their association with the node of Ranvier, the synapse, and capillaries is
indicative of the role they play in signal conduction and mediating the permeability of the
blood–brain barrier. In summary, astrocytes remove excitatory amino acids (EAAs) such
as glutamate, release neurotrophic factors, and metabolize neurotransmitters (Fields and
Stevens-Graham 2002; Koehler et al. 2009). As mentioned earlier, astrocytes are also
necessary for maintaining the redox homeostasis of neurons by releasing GSH and its
precursor cysteine for uptake by neurons, which is important as cysteine is the rate-limiting
component of the GSH synthesis pathway (Sagara et al. 1993; O’Connor et al. 1995;
Dringen et al. 1999).
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their aforementioned role in the brain. While MeHg affects numerous cell types, Aschner
et al. (2000) showed MeHg preferentially accumulates in astrocytes and to a lesser extent
microglial cells. MeHg is thought to affect the function of astrocytes and produce neuronal
damage in numerous ways. These include the induction of swelling in astrocytes that
results in the release of EAA, the production of ROS, interfering with redox homeostasis
and disturbing the uptake of glutamate, the result of which is the induction of oxidative
stress and excitotoxicity in neurons (Aschner et al. 2000). This suggests a plausible
mechanism for the presence of oxidative stress in autism.
Excitotoxicity is defined as being the chronic and abnormal excitatory stimulation of
susceptible neurons by EAA (Blaylock and Strunecka 2009). The common neurotrans-
mitter glutamate is controlled due to its high toxicity. If the levels of glutamate in the
synaptic cleft are allowed to get too high, then this leads to chronic activation which
ultimately results in the excessive influx of Ca
2þ into the cytoplasm. This activates two
problematic enzymatic pathways, the protein kinase C pathway and the inducible nitric
oxide synthase pathway, both of which eventually lead to the generation of ROS and thus
damages both mitochondria and cellular function (Blaylock and Strunecka 2009).
There is growing evidence that excitotoxicity during the early vulnerable periods of
neural development is involved in the etiology of neurodevelopmental disorders such as
autism (Blaylock and Strunecka 2009). A recent study by Ferraro et al. (2009) examined
the effect on rat pups of prenatal exposure to a single dose of MeHg on neurochemistry
and long-term cognitive function. Data showed a significant effect on microtubule
production, resulting in the disruption of the developing neuronal network. The role of
glutamate excitotoxicity was suggested as possibly playing a role in producing cell death
among neuronal cell cultures. It was also suggested that the neural damage from prenatal
exposure to MeHg impaired long-term adult memory evidenced by the significant
deficiencies in retention performance in adult pups. This study suggests that prenatal
exposure to Hg may exert long lasting effects on brain development in animals that are
broadly analogous to autism in humans.
Immunotoxicity involves the overactivation of the innate immune system resulting in
inflammation and autoimmunity (Schwenk et al. 2009). Microglial cells respond to
neuronal activity and are able to produce inflammatory immune responses as well as
remove cellular debris and apoptotic cells (Fields and Stevens-Graham 2002). The
overproduction of cytokines and recruitment of the innate immune system by early and
chronic activation of microglial cells and astrocytes was suggested to be one of the
underlying mechanisms of immunotoxicity in autism (Dietert and Dietert 2008). Recently,
Hung et al. (2010) showed that normal brain activity supresses microglial cells and
stimulation of neurons activates inflammatory responses from microglial cells. This not
only demonstrates that the interaction of glial cells with the brain is able to produce
immune responses, but also presents the possiblity that abnormal exicitation and
excitotoxicity might play a role in immune dysfunction such as that found in autism
(Pardo et al. 2006; Blaylock and Strunecka 2009).
As outlined by Schwenk et al. (2009), Hg was shown to actively increase the reactivity
of the immune system in rodents. This immunostimulation led to the development of
immunotoxic problems such as allergeric responses and autoimmune disease. A new study
(Kempuraj et al. 2010) found that Hg induces release of inflammatory cytokines from
human mast cells that may interfer with the blood–brain barrier and produce
neuroinflamination. Data indicated that Hg-related immunotoxic repsonse may be one
of the underlying mechanisms in the etiology of autism. In fact, increased activation of
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et al. 2005). This activation was proposed to result in neuroinflamination due to the
up-regulation of inflamatory cytokines resulting in changes to neuronal and synpatic
functions. Markers of increased immune activation and autoimmunity (e.g., cytokine
interleukin-12 and anti-neuronal antibodies) were also linked to autism in a several studies
(Singh 1996; Singh et al. 1997) suggesting a possible role of immuntoxicity in the
pathophysiology of autism. It is reasonable to presume that Hg may be involved in this
suggested immunological pathology or, at the very least, in the abnormal cellular
mechanisms observed in autistic children.
Conclusions
From a cellular perspective, it would appear that the existing scientific literature supports
the biological plausibility of a Hg-based autism pathogenesis. Hg has well-known effects
relating to the disruption of sulfur chemistry leading to elevated oxidative stress which, in
turn, results into broader physiological/organ affects, particularly to the CNS. Oxidative
stress was consistently elevated in autism. Although this is not unique to autism (as many
disease states are associated with this biochemical characteristic), it does suggest that
autism is more than just a neurological disease but also a disease which reflects
dysfunction at various metabolic levels. Nevertheless, research studies identifying Hg’s
effects on glial cells and mitochondria that are consistent with findings in autistic patients,
lend further support to the Hg-autism hypothesis.
To understand the case for plausibility, it is essential to recognize that a critical
variable (or unpredictable confound as the case may be) is the idiosyncratic sensitivity of
any given individual to Hg, which likely has some genetic basis. As experienced through
the pink disease epidemic, this variable is unpredictable a priori of exposure, and so the
only way to end the pink disease epidemic was to minimize Hg exposure to all children. If
Hg is indeed an etiological agent in autism, it is likely to require a similar global response
as one cannot identify ‘‘at risk’’ children. This population level approach to reducing Hg
exposure has not, as of yet, been comprehensively introduced, with the exception of partial
Hg reduction in the vaccine schedule, and warning the public (especially pregnant and
nursing mothers) regarding the consumption of seafood.
Despite the biological plausibility of Hg as an etiological agent in autism, there remains
a great deal of work to do in order to better understand how Hg acts in any pathogenic
process. Obviously, there is a need to establish the broad range of Hg affects across various
exposure models. For example, future studies are urgently required utilizing both animal
and in vitro cellular methods that manipulate Hg species, dose frequency, and mode of
administration (e.g., oral and parenteral), as well as individual difference variables such as
age of animal (including varying stages of gestational age) and known genetic variants.
Outcome variables need to include not just behavioral analogs of autism but a wide range
of physiological variables known to be associated with Hg damage including urinary
PrCP, markers of oxidative stress, and genetic variables.
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